Docoh
Loading...

21 results

Filter options loading...
Top filers
Top filing types
Recent filing years
8-K
EX-99.1
PRPO Precipio Inc
21 Feb 05
Other Events
7:00pm
) that was developed for automated culture-independent molecular analysis of mixed microbial communities. This extension of the WAVE(R) System product line
S-3/A
PRPO Precipio Inc
9 Apr 20
Shelf registration (amended)
1:53pm
for their diagnostic interpretation. Our Technology We have developed IV-Cell, a proprietary culture media that addresses the problem of selective culturing … , a proprietary culture media that addresses the problem of selective culturing – by creating a universal media that enables simultaneous culturing of all 4
S-3
PRPO Precipio Inc
27 Mar 20
Shelf registration
4:51pm
interpretation. Our Technology We have developed IV-Cell, a proprietary culture media that addresses the problem of selective culturing – by creating … process, and the technician is able to select any of the 4 lineages during the culturing process. IV-Cell We have developed IV-Cell, a proprietary culture
424B3
PRPO Precipio Inc
30 Jan 20
Prospectus supplement
5:09pm
for convenience upon 180 days’ prior written notice. IV-Cell The diagnostic process of hematopoietic diseases involves conducting cell-culture tests … . In most cases, due to specimen limitation, low cellularity, or cell viability, the cytogeneticist can select only one of the above cell lines to culture
424B5
PRPO Precipio Inc
2 Apr 21
Prospectus supplement for primary offering
2:00pm
or are paid by us for their diagnostic interpretation. Our Technology We have developed IV-Cell, a proprietary culture media that addresses the problem … We have developed IV-Cell, a proprietary culture media that addresses the problem of selective culturing – by creating a universal media that enables
S-1
l4pz3y5rmh13m
14 Jan 20
IPO registration
4:26pm
S-1/A
qw866dixn zkmh0baier
27 Jan 20
IPO registration (amended)
4:47pm
424B3
nu1aiksu0q25ls8
7 Jul 20
Prospectus supplement
5:27pm
424B3
aybk7l3 qqeqwktsk7
13 Apr 20
Prospectus supplement
4:55pm
424B3
emv4enxa
21 Aug 19
Prospectus supplement
5:28pm
S-1
syl1dvdq9x
9 Aug 19
IPO registration
3:47pm
S-1/A
e8ms4b7 wyx
8 Apr 20
IPO registration (amended)
3:41pm
S-1
5dfjff9mvr0kxojaqc
27 Mar 20
IPO registration
4:31pm
S-1
qjoml68
26 Jun 20
IPO registration
5:18pm
10-K
5p46 7ceuyka4
29 Mar 21
Annual report
4:29pm
10-K
27046d gq7mo74o4
16 Apr 19
Annual report
5:20pm
10-K
ehgw4u22usqzt1z63i
27 Mar 20
Annual report
3:47pm
8-K/A
EX-10.1
bfg0x9s1ry2g7vo7i
30 Jul 17
Entry into a Material Definitive Agreement
8:00pm
DEF 14A
tm26cn0yotl y3
29 Apr 19
Definitive proxy
5:22pm
DEF 14A
qhgdfb sgfqk
29 Apr 21
Definitive proxy
4:31pm